Cargando…
Ruxolitinib rechallenge in combination with hydroxyurea is effective in reverting cachexia and reducing blood transfusion demand and splenomegaly symptoms in a patient with primary myelofibrosis
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer Berlin Heidelberg
2017
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5334413/ https://www.ncbi.nlm.nih.gov/pubmed/28197723 http://dx.doi.org/10.1007/s00277-017-2938-5 |
| _version_ | 1782511848245952512 |
|---|---|
| author | Cerchione, Claudio Peluso, Ilaria Nappi, Davide Pareto, Anna Emanuele Picardi, Marco Martinelli, Vincenzo Pane, Fabrizio |
| author_facet | Cerchione, Claudio Peluso, Ilaria Nappi, Davide Pareto, Anna Emanuele Picardi, Marco Martinelli, Vincenzo Pane, Fabrizio |
| author_sort | Cerchione, Claudio |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5334413 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2017 |
| publisher | Springer Berlin Heidelberg |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-53344132017-03-15 Ruxolitinib rechallenge in combination with hydroxyurea is effective in reverting cachexia and reducing blood transfusion demand and splenomegaly symptoms in a patient with primary myelofibrosis Cerchione, Claudio Peluso, Ilaria Nappi, Davide Pareto, Anna Emanuele Picardi, Marco Martinelli, Vincenzo Pane, Fabrizio Ann Hematol Letter to the Editor Springer Berlin Heidelberg 2017-02-14 2017 /pmc/articles/PMC5334413/ /pubmed/28197723 http://dx.doi.org/10.1007/s00277-017-2938-5 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
| spellingShingle | Letter to the Editor Cerchione, Claudio Peluso, Ilaria Nappi, Davide Pareto, Anna Emanuele Picardi, Marco Martinelli, Vincenzo Pane, Fabrizio Ruxolitinib rechallenge in combination with hydroxyurea is effective in reverting cachexia and reducing blood transfusion demand and splenomegaly symptoms in a patient with primary myelofibrosis |
| title | Ruxolitinib rechallenge in combination with hydroxyurea is effective in reverting cachexia and reducing blood transfusion demand and splenomegaly symptoms in a patient with primary myelofibrosis |
| title_full | Ruxolitinib rechallenge in combination with hydroxyurea is effective in reverting cachexia and reducing blood transfusion demand and splenomegaly symptoms in a patient with primary myelofibrosis |
| title_fullStr | Ruxolitinib rechallenge in combination with hydroxyurea is effective in reverting cachexia and reducing blood transfusion demand and splenomegaly symptoms in a patient with primary myelofibrosis |
| title_full_unstemmed | Ruxolitinib rechallenge in combination with hydroxyurea is effective in reverting cachexia and reducing blood transfusion demand and splenomegaly symptoms in a patient with primary myelofibrosis |
| title_short | Ruxolitinib rechallenge in combination with hydroxyurea is effective in reverting cachexia and reducing blood transfusion demand and splenomegaly symptoms in a patient with primary myelofibrosis |
| title_sort | ruxolitinib rechallenge in combination with hydroxyurea is effective in reverting cachexia and reducing blood transfusion demand and splenomegaly symptoms in a patient with primary myelofibrosis |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5334413/ https://www.ncbi.nlm.nih.gov/pubmed/28197723 http://dx.doi.org/10.1007/s00277-017-2938-5 |
| work_keys_str_mv | AT cerchioneclaudio ruxolitinibrechallengeincombinationwithhydroxyureaiseffectiveinrevertingcachexiaandreducingbloodtransfusiondemandandsplenomegalysymptomsinapatientwithprimarymyelofibrosis AT pelusoilaria ruxolitinibrechallengeincombinationwithhydroxyureaiseffectiveinrevertingcachexiaandreducingbloodtransfusiondemandandsplenomegalysymptomsinapatientwithprimarymyelofibrosis AT nappidavide ruxolitinibrechallengeincombinationwithhydroxyureaiseffectiveinrevertingcachexiaandreducingbloodtransfusiondemandandsplenomegalysymptomsinapatientwithprimarymyelofibrosis AT paretoannaemanuele ruxolitinibrechallengeincombinationwithhydroxyureaiseffectiveinrevertingcachexiaandreducingbloodtransfusiondemandandsplenomegalysymptomsinapatientwithprimarymyelofibrosis AT picardimarco ruxolitinibrechallengeincombinationwithhydroxyureaiseffectiveinrevertingcachexiaandreducingbloodtransfusiondemandandsplenomegalysymptomsinapatientwithprimarymyelofibrosis AT martinellivincenzo ruxolitinibrechallengeincombinationwithhydroxyureaiseffectiveinrevertingcachexiaandreducingbloodtransfusiondemandandsplenomegalysymptomsinapatientwithprimarymyelofibrosis AT panefabrizio ruxolitinibrechallengeincombinationwithhydroxyureaiseffectiveinrevertingcachexiaandreducingbloodtransfusiondemandandsplenomegalysymptomsinapatientwithprimarymyelofibrosis |